fluphenazine has been researched along with Depression in 83 studies
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Excerpt | Relevance | Reference |
---|---|---|
"Fluphenazine levels, side effects, depression and psychosocial outcome were measured at five time points over approximately 1 year in 59 recent onset schizophrenic patients treated with a maintenance dose of injectable fluphenazine decanoate." | 9.09 | Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression. ( Aravagiri, M; Bartzokis, G; Fogelson, D; Gitlin, MJ; Mintz, J; Nuechterlein, KH; Subotnik, K; Ventura, J, 2000) |
"A 1 year double-blind trial of bromperidol decanoate and fluphenazine decanoate was conducted in the maintenance treatment of 47 outpatients with schizophrenia." | 9.07 | Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. ( Cookson, JC; McLaren, S; Silverstone, T, 1992) |
" A controlled clinical trial has shown oral pimozide to be clinically at least as effective as fluphenazine decanoate in the continuation treatment of schizophrenia." | 9.04 | Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide. ( Shepherd, M, 1979) |
"Patients suffering from mixed anxiety/depressive reactions, referred to the out-patient department of a large psychiatric hospital, were treated with either amitriptyline tablets or fluphenazine with nortriptyline (f/n) tablets for a period of four weeks." | 9.04 | A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states. ( Bennie, EH; Schiff, AA, 1976) |
"A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipal) and its major metabolite, tofenacin hydrochloride (Elamol) on the Parkinsonian side-effects and depression occurring during fluphenazine decanoate therapy." | 9.04 | A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. ( Capstick, N; Pudney, H, 1976) |
"Patients suffering from mixed anxiety/depressive states referred to a psychiatric out-patient clinic completed a four course of either a once-daily table of 30 mg nortriptyline with 1-5 mag fluphenazine, or a sustained release capsule of 50 mg amitriptyline once daily, on a double-blind basis." | 9.04 | Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline. ( Magnus, RV; Schiff, AA, 1977) |
"A double-blind study involving sixty-two patients, aged 65 years or over, treated for twenty-eight days, showed that fluphenazine 0-5 mg/nortriptyline 10 mg three times daily was superior to promazine 50 mg three times daily in relieving symptoms of anxiety and was associated with a lower incidence of side-effects." | 9.04 | Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine. ( Brodie, NH; McGhie, RL; O'Hara, H; Schiff, AA; Valle-Jones, JC, 1975) |
"Fluphenazine levels, side effects, depression and psychosocial outcome were measured at five time points over approximately 1 year in 59 recent onset schizophrenic patients treated with a maintenance dose of injectable fluphenazine decanoate." | 5.09 | Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression. ( Aravagiri, M; Bartzokis, G; Fogelson, D; Gitlin, MJ; Mintz, J; Nuechterlein, KH; Subotnik, K; Ventura, J, 2000) |
"A 1 year double-blind trial of bromperidol decanoate and fluphenazine decanoate was conducted in the maintenance treatment of 47 outpatients with schizophrenia." | 5.07 | Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates. ( Cookson, JC; McLaren, S; Silverstone, T, 1992) |
"Fifty-seven patients with a diagnosis of schizophrenia were started on either fluphenazine decanoate or flupenthixol decanoate injections in a double-blind trial just prior to discharge into the community." | 5.04 | Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients. ( Hirsch, SR; Knights, A; Okasha, MS; Salih, MA, 1979) |
" A controlled clinical trial has shown oral pimozide to be clinically at least as effective as fluphenazine decanoate in the continuation treatment of schizophrenia." | 5.04 | Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide. ( Shepherd, M, 1979) |
"Patients suffering from mixed anxiety/depressive reactions, referred to the out-patient department of a large psychiatric hospital, were treated with either amitriptyline tablets or fluphenazine with nortriptyline (f/n) tablets for a period of four weeks." | 5.04 | A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states. ( Bennie, EH; Schiff, AA, 1976) |
"A trial involving patients receiving fluphenazine decanoate was designed to compare the effects of orphenadrine hydrochloride (Disipal) and its major metabolite, tofenacin hydrochloride (Elamol) on the Parkinsonian side-effects and depression occurring during fluphenazine decanoate therapy." | 5.04 | A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. ( Capstick, N; Pudney, H, 1976) |
"Patients suffering from mixed anxiety/depressive states referred to a psychiatric out-patient clinic completed a four course of either a once-daily table of 30 mg nortriptyline with 1-5 mag fluphenazine, or a sustained release capsule of 50 mg amitriptyline once daily, on a double-blind basis." | 5.04 | Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline. ( Magnus, RV; Schiff, AA, 1977) |
"A double-blind study involving sixty-two patients, aged 65 years or over, treated for twenty-eight days, showed that fluphenazine 0-5 mg/nortriptyline 10 mg three times daily was superior to promazine 50 mg three times daily in relieving symptoms of anxiety and was associated with a lower incidence of side-effects." | 5.04 | Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine. ( Brodie, NH; McGhie, RL; O'Hara, H; Schiff, AA; Valle-Jones, JC, 1975) |
" In latent of manifest glaucoma (7 patients) Clomipramine increased the tonography in 1 case, whereas Amitriptyline and Noxiptiline reduced it in 4 cases." | 3.65 | [Psychotropic drugs and glaucoma (author's transl)]. ( Andrée, G; Meiser, H; Schmitt, W, 1976) |
"Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection." | 3.65 | Severe depressive mood changes following slow-release intramuscular fluphenazine injection. ( Carney, MW; De Alarcon, R, 1969) |
"Fluphenazine decanoate treatment causes significantly more depressive syndromes than does placebo." | 2.64 | [Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)]. ( Kind, J; Müller, P; Steuber, H, 1978) |
"Relapse was accompanied by a resurgence of specifically schizophrenic symptoms and by an increase in abnormalities described by the relatives." | 2.64 | Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. ( Gaind, R; Hirsch, SR; Rohde, PD; Stevens, BC; Wing, JK, 1973) |
"The results of treating 251 therapeutically resistant patients with paranoid schizophrenia by moditen-depo, its combination with other psychotic drugs or leponex was compared." | 1.26 | [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex]. ( Aranovich, AG; Gamburg, AL; Kotel'kevich, IuN; Omorokov, BM; Rasniuk, VA, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 77 (92.77) | 18.7374 |
1990's | 3 (3.61) | 18.2507 |
2000's | 1 (1.20) | 29.6817 |
2010's | 2 (2.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vivier, D | 1 |
Bennis, K | 1 |
Lesage, F | 1 |
Ducki, S | 1 |
Rasmusson, RL | 1 |
Anumonwo, JM | 1 |
KNOBEL, M | 1 |
UCHAUDABE, R | 1 |
MARCHIONNI, KH | 1 |
UCHAUDABE, N | 1 |
BENZECRY, E | 1 |
ROMAN, EC | 1 |
MARTINO, PA | 1 |
TRIPOLI, PF | 1 |
LOIANNO, R | 1 |
LEHMANN, HE | 1 |
BAN, TA | 1 |
INVERNIZZI, G | 1 |
CAMBA, ME | 1 |
PARDO, RF | 1 |
GANDARALAMAS, M | 1 |
ABOAB, R | 1 |
ECKMANN, F | 1 |
IMMICH, H | 1 |
RECH, RH | 1 |
Hartmann, W | 1 |
Kind, J | 2 |
Meyer, JE | 1 |
Müller, P | 2 |
Steuber, H | 2 |
Gamburg, AL | 1 |
Aranovich, AG | 1 |
Kotel'kevich, IuN | 1 |
Omorokov, BM | 1 |
Rasniuk, VA | 1 |
Wistedt, B | 1 |
Ranta, J | 1 |
Conway, JF | 1 |
Valle-Jones, JC | 3 |
O'Hara, J | 2 |
O'Hara, H | 3 |
McGhie, RL | 3 |
Brodie, NH | 3 |
Anderson, JA | 1 |
Schiff, AA | 6 |
Siris, SG | 2 |
Cooper, TB | 1 |
Rifkin, AE | 1 |
Brenner, R | 1 |
Lieberman, JA | 1 |
Kosten, TR | 1 |
Camp, W | 1 |
Yee, CM | 1 |
Nuechterlein, KH | 2 |
Morris, SE | 1 |
White, PM | 1 |
Gitlin, MJ | 1 |
Mintz, J | 1 |
Fogelson, D | 1 |
Bartzokis, G | 1 |
Ventura, J | 1 |
Subotnik, K | 1 |
Aravagiri, M | 1 |
Donlon, PT | 2 |
Rada, RT | 1 |
Arora, KK | 1 |
Johnson, DA | 2 |
Nelson, JC | 1 |
Bowers, MB | 1 |
Falloon, I | 1 |
Watt, DC | 1 |
Shepherd, M | 2 |
Knights, A | 1 |
Okasha, MS | 1 |
Salih, MA | 1 |
Hirsch, SR | 2 |
Stevenson, IH | 1 |
Wilson, NM | 1 |
Bennie, EH | 1 |
Capstick, N | 1 |
Pudney, H | 1 |
Floru, L | 1 |
Heinrich, K | 1 |
Wittek, F | 1 |
Magnus, RV | 1 |
Pawelkiewicz, K | 1 |
Sekrecki, T | 1 |
Baker, PM | 1 |
Bartholomeusz, DB | 1 |
Siskind, M | 1 |
Whitlock, FA | 1 |
König, L | 1 |
Lange, E | 1 |
Cook, AR | 1 |
Andrée, G | 1 |
Schmitt, W | 1 |
Meiser, H | 1 |
Carney, MW | 3 |
Sheffield, BF | 2 |
Ayd, FJ | 4 |
Woodward, JA | 1 |
Henry, BW | 1 |
Overall, JE | 1 |
McLaren, S | 1 |
Cookson, JC | 1 |
Silverstone, T | 1 |
Cervo, L | 1 |
Grignaschi, G | 1 |
Samanin, R | 1 |
Carotti, P | 1 |
Merli, R | 1 |
Adan, F | 1 |
Cohen, M | 1 |
Mandeli, J | 1 |
Aronson, A | 1 |
Fasano-Dube, B | 1 |
Blacker, KH | 1 |
Keskiner, A | 1 |
Escande, M | 1 |
Vasquez Villareal, S | 1 |
Gayral, L | 1 |
Ucko, FA | 1 |
Meltzer, HY | 1 |
Sachar, EJ | 1 |
Frantz, AG | 1 |
Anderson, J | 1 |
Lambert, NG | 1 |
Pigott, PV | 2 |
Gaind, R | 1 |
Rohde, PD | 1 |
Stevens, BC | 1 |
Wing, JK | 1 |
Faleni, R | 1 |
Cia, A | 1 |
Gravel, LL | 1 |
Bédard, P | 1 |
Frenette, M | 1 |
Hillel, J | 1 |
Albert, JM | 1 |
Rickels, K | 1 |
Jenkins, BW | 1 |
Zamostien, B | 1 |
Raab, E | 1 |
Kanther, M | 1 |
Simpson, GM | 1 |
Baldini, JT | 1 |
Neary, ER | 1 |
Ota, KY | 1 |
Turek, I | 1 |
Berman, SA | 1 |
Kurland, AA | 1 |
Kernohan, GA | 1 |
Ray, I | 1 |
Andrews, WN | 1 |
Uno, M | 1 |
Ledererová, E | 1 |
Toman, M | 1 |
Grof, P | 1 |
Wallerstein, E | 1 |
Dykyj, R | 1 |
Nodine, JH | 1 |
Marjot, DH | 1 |
Núnek, K | 1 |
West, D | 1 |
Bauer, A | 1 |
Mosler, A | 1 |
Clarke, FC | 1 |
De Alarcon, R | 1 |
Johnson, J | 1 |
Imlah, NW | 1 |
Forrest, AD | 1 |
Segal, M | 1 |
Ropschitz, DH | 1 |
Petrilowitsch, N | 1 |
Herzog, R | 1 |
3 reviews available for fluphenazine and Depression
Article | Year |
---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc | 2016 |
The depot fluphenazines: a reappraisal after 10 years' clinical experience.
Topics: Administration, Oral; Adult; Age Factors; Aged; Ambulatory Care; Basal Ganglia Diseases; Child; Dela | 1975 |
Side effects of depot fluphenazines.
Topics: Agranulocytosis; Barbiturates; Basal Ganglia Diseases; Benztropine; Biperiden; Delayed-Action Prepar | 1974 |
30 trials available for fluphenazine and Depression
Article | Year |
---|---|
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixo | 1983 |
Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Drug Combinations; Female; Flupenthixol; Fluphena | 1981 |
Doctor's versus patient's judgement in the assessment of mixed anxiety/depressive illness. Implications for measurement of therapeutic response.
Topics: Adult; Aged; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Drug Combinations; Female; | 1981 |
P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Anxiety; Attention; Cognition; Depression; Evoked | 1998 |
Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression.
Topics: Adult; Antipsychotic Agents; Depression; Female; Fluphenazine; Half-Life; Humans; Individuality; Mal | 2000 |
A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
Topics: Adult; Clinical Trials as Topic; Depression; Female; Fluphenazine; Humans; Male; Pimozide; Recurrenc | 1978 |
Maprotiline and fluphenazine/nortriptyline in depression.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Therapy, C | 1978 |
[Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)].
Topics: Clinical Trials as Topic; Depression; Fluphenazine; Humans; Placebos; Schizophrenia; Sex Factors | 1978 |
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Depression; Flupenthixol; | 1979 |
Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
Topics: Adolescent; Adult; Clinical Trials as Topic; Depression; Fluphenazine; Humans; Middle Aged; Pimozide | 1979 |
A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states.
Topics: Adolescent; Adult; Aged; Amitriptyline; Anxiety; Clinical Trials as Topic; Depression; Drug Combinat | 1976 |
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
Topics: Clinical Trials as Topic; Depression; Fluphenazine; Humans; Orphenadrine; Parkinson Disease, Seconda | 1976 |
The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depression; Female; Flupenthixol; Fluphenazi | 1975 |
Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline.
Topics: Adolescent; Adult; Aged; Amitriptyline; Anxiety; Depression; Drug Combinations; Fluphenazine; Humans | 1977 |
Anxiety/depression in elderly patients. A double-blind comparative study of fluphenazine/nortriptyline and promazine.
Topics: Age Factors; Aged; Anxiety; Clinical Trials as Topic; Depression; Fluphenazine; Humans; Nitrazepam; | 1975 |
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
Topics: Adult; Aged; Chronic Disease; Depression; Double-Blind Method; Female; Fluphenazine; Haloperidol; Hu | 1992 |
Separate and combined anxiolytic and anti-depressant treatment of mixed anxiety/depression. A double-blind, placebo controlled comparison. Sussex Clinical Trials Group.
Topics: Adolescent; Adult; Aged; Anxiety; Depression; Double-Blind Method; Drug Combinations; Female; Fluphe | 1985 |
Targeted treatment of depression-like symptoms in schizophrenia.
Topics: Benztropine; Depression; Drug Therapy, Combination; Fluphenazine; Humans; Imipramine; Schizophrenia | 1987 |
Psychotropics in anxiety and depression--combination or single agent?
Topics: Administration, Oral; Adolescent; Adult; Aged; Amitriptyline; Anxiety; Clinical Trials as Topic; Dep | 1970 |
An evaluation of fluphenazine with nortriptyline in anxiety and depression.
Topics: Amitriptyline; Anxiety; Clinical Trials as Topic; Depression; Drug Combinations; Fluphenazine; Human | 1972 |
Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Delayed-Action | 1973 |
A review of clinical studies with combinations of fluphenazine and nortriptyline.
Topics: Amitriptyline; Anxiety; Central Nervous System; Clinical Trials as Topic; Depression; Diazepam; Doxe | 1972 |
Motival in the treatment of anxious depression.
Topics: Adult; Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depression; Drug Synergism; Female; | 1972 |
Pharmacotherapy in neurotic depression. Differential population responses.
Topics: Adult; Amitriptyline; Clinical Trials as Topic; Depression; Female; Fluphenazine; Humans; Male; Midd | 1967 |
Long-acting phenothiazines in schizophrenia.
Topics: Administration, Oral; Clinical Trials as Topic; Delayed-Action Preparations; Depression; Fluphenazin | 1971 |
Controlled trials of an amitriptyline-fluphenazine combination in depressive neuroses and psychoses: a collaborative study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depression; Fluphenazine; Humans; | 1970 |
A comparative study of fluphenazine-amitriptyline combination and amitriptyline alone in the treatment of depressed psychiatric patients.
Topics: Adult; Amitriptyline; Clinical Trials as Topic; Depression; Female; Fluphenazine; Humans; Male; Midd | 1970 |
[Experience with fluphenazine in the treatment of anxiety in endogenous depressions. (Orientational comparison with chlorpromazine in an intensive double-blind study].
Topics: Adult; Anxiety Disorders; Chlorpromazine; Clinical Trials as Topic; Depression; Female; Fluphenazine | 1966 |
Fluphenazine and amitriptyline in the anxious depressed patient.
Topics: Amitriptyline; Anxiety; Clinical Trials as Topic; Depression; Drug Synergism; Fluphenazine; Humans; | 1967 |
[Treatment of skin parasite delusion].
Topics: Aged; Delusions; Dementia; Depression; Female; Fluphenazine; Humans; Hydrocephalus; Intracranial Art | 1970 |
50 other studies available for fluphenazine and Depression
Article | Year |
---|---|
Activation of HERG channels: opening new applications for the biophysics of antiarrhythmic therapy.
Topics: Depression; Fluphenazine; Humans | 2015 |
[CLINICAL EXPERIENCE WITH FLUPHENAZINE DIHYDROCHLORIDE, A BROADSPECTRUM TRANQUILIZING AGENT].
Topics: Anxiety; Anxiety Disorders; Depression; Fluphenazine; Humans; Hypertension; Mental Disorders; Sleep | 1963 |
[FLUPHENAZINE CLINICAL AND OPHTHALMOLOGICAL PRACTICE].
Topics: Anxiety; Anxiety Disorders; Blindness; Cataract; Deafness; Depression; Fluphenazine; Glaucoma; Hemia | 1963 |
[CLINICAL EXPERIENCES WITH FLUPHENAZINE. REPEATED-ACTION DRAG'EES].
Topics: Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Cardiovascular Diseases; Delayed-Acti | 1963 |
NOTES FROM THE LOG-BOOK OF A PSYCHOPHARMACOLOGICAL RESEARCH UNIT I.
Topics: Amobarbital; Behavior; Books; Chlordiazepoxide; Depression; Dextroamphetamine; Electroconvulsive The | 1964 |
[OBSERVATIONS ON THE USE OF PHENYLPYRROLIDINOPENTANE AS AN ANTIASTHENIC AGENT IN TREATMENT WITH PSYCHOPHARMACOLOGICAL DRUGS].
Topics: Amitriptyline; Anxiety; Anxiety Disorders; Asthenia; Bipolar Disorder; Chemical and Drug Induced Liv | 1964 |
[FLUPHENAZINE DIHYDROCHLORIDE].
Topics: Achlorhydria; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Dyspepsia; Feeding and Ea | 1964 |
[FLUPHANAZINE IN TENSION AND DEPRESSION].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Fluphenazine; Humans; Mental Disorders; | 1963 |
[NEUROLEPTICS AND DYSKINETIC REACTIONS].
Topics: Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Chlorprothixene; Depression; Fluphenazine; M | 1963 |
ANTAGONISM OF RESERPINE BEHAVIORAL DEPRESSION BY D-AMPHETAMINE.
Topics: Amphetamine; Amphetamines; Animals; Avoidance Learning; Behavior, Animal; Brain Chemistry; Depressio | 1964 |
Neuroleptic drugs and the prevention of relapse in schizophrenia: a workshop report.
Topics: Aggression; Akinetic Mutism; Ambulatory Care; Antipsychotic Agents; Depression; Diagnosis, Different | 1980 |
[Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Delayed-Action Preparatio | 1980 |
Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Topics: Adult; Delayed-Action Preparations; Depression; Drug Interactions; Drug Therapy, Combination; Female | 1982 |
Inappropriate secretion of antidiuretic hormone in a patient receiving piperazine phenothiazines.
Topics: Depression; Female; Fluphenazine; Humans; Inappropriate ADH Syndrome; Middle Aged; Syndrome | 1980 |
Depression and the reintegration phase of acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Brief Psychiatric Rating Scale; Cognition Disorders; Depression; F | 1976 |
Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Depression; Drug Implants; Fluph | 1977 |
Delusional unipolar depression: description and drug response.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Delusions; Depression; Fema | 1978 |
Implications of dose regimen and protein binding for plasma nortriptyline estimations.
Topics: Adult; Biological Availability; Blood Proteins; Depression; Drug Administration Schedule; Female; Fl | 1978 |
[Depr;essive syndrome in the course of treatment with Mirenil prolongatum].
Topics: Acute Disease; Adult; Delayed-Action Preparations; Depression; Female; Fluphenazine; Humans; Neuroti | 1977 |
Drug-induced depression and attempted suicide.
Topics: Alcoholism; Depression; Drug-Related Side Effects and Adverse Reactions; Female; Fluphenazine; Human | 1977 |
[Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Cyclothymic Disorder; Depression; Depressive Disorder, Maj | 1976 |
Psychotropic drugs in depot form.
Topics: Amitriptyline; Depression; Flupenthixol; Fluphenazine; Humans; Injections, Intravenous | 1976 |
[Psychotropic drugs and glaucoma (author's transl)].
Topics: Adult; Aged; Clomipramine; Depression; Desipramine; Dibenzocycloheptenes; Female; Fluphenazine; Glau | 1976 |
Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Delayed-Action Preparations; Depression; Female; Fl | 1976 |
Therapy with injectable fluphenazines.
Topics: Acute Disease; Age Factors; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Delayed-Action | 1976 |
Patterns of symptom change in anxious depressed outpatients treated with different drugs.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Depression; Desipra | 1975 |
The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test.
Topics: Animals; Depression; Desipramine; Dopamine; Fluphenazine; Hydroxydopamines; Injections; Limbic Syste | 1990 |
[Considerations on the use of long-acting neuroleptics in a mental health center].
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Depression; Fluphenazine; | 1986 |
Stages of schizophrenic decompensation and reintegration.
Topics: Adult; Affect; Aggression; Antipsychotic Agents; Anxiety; Depression; Desipramine; Fear; Female; Flu | 1973 |
A long-term follow-up of fluphenazine enanthate treatment.
Topics: Adult; Blood Glucose; Depression; Female; Fluphenazine; Follow-Up Studies; Humans; Male; Middle Aged | 1973 |
The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Catatonia; Depression; Female; Fluphenazine; Hospitalizati | 1973 |
[Incidents and accidents during therapy with long-acting neuroleptics].
Topics: Amenorrhea; Autonomic Nervous System; Body Weight; Delayed-Action Preparations; Depression; Eye Mani | 1974 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
Elamol and Motival-new psychotropic drugs?
Topics: Animals; Anxiety; Depression; Fluphenazine; Humans; Nortriptyline; Orphenadrine | 1972 |
[Home treatment in the Bayonne community].
Topics: Adult; Amitriptyline; Costs and Cost Analysis; Depression; Family; Family Therapy; Female; Fluphenaz | 1973 |
Comparative trial of low dose haloperidol and fluphenazine in office patients.
Topics: Adult; Affect; Aged; Depression; Evaluation Studies as Topic; Female; Fluphenazine; Haloperidol; Hum | 1972 |
Long-acting phenothiazine preparations in the treatment of schizophrenia.
Topics: Basal Ganglia Diseases; Delayed-Action Preparations; Depression; Fluphenazine; Humans; Injections, I | 1972 |
Amotivational syndrome.
Topics: Antidepressive Agents; Canada; Community Mental Health Services; Depression; Fluphenazine; Humans; M | 1972 |
[Follow-up studies of schizophrenia].
Topics: Adult; Catalepsy; Catatonia; Chlorpromazine; Chronic Disease; Convulsive Therapy; Depersonalization; | 1971 |
Depression following fluphenazine treatment.
Topics: Chlorpromazine; Depression; Fluphenazine; Humans; Phenothiazines; Schizophrenia; Thioridazine | 1969 |
[Current problems of endogenous depression].
Topics: Amitriptyline; Antidepressive Agents; Chlorpromazine; Convulsive Therapy; Depression; Desipramine; F | 1970 |
Dangers of fluphenazine.
Topics: Depression; Fluphenazine; Humans; Nausea; Parkinson Disease, Secondary; Vomiting | 1970 |
Dangers of fluphenazine.
Topics: Administration, Oral; Depression; Fluphenazine; Humans; Phenothiazines; Suicide | 1971 |
The treatment of depression in general practice.
Topics: Adult; Aged; Depression; Dextroamphetamine; Dibenzazepines; Family Practice; Female; Fluphenazine; H | 1969 |
Severe depressive mood changes following slow-release intramuscular fluphenazine injection.
Topics: Adult; Delayed-Action Preparations; Depression; Electroconvulsive Therapy; Female; Fluphenazine; Hum | 1969 |
Depressive changes after fluphenazine treatment.
Topics: Depression; Fluphenazine; Humans; Psychoses, Substance-Induced; Schizophrenia | 1969 |
Depressive changes after fluphenazine treatment.
Topics: Depression; Fluphenazine; Humans; Schizophrenia; Suicide | 1969 |
Depressive changes after fluphenazine treatment.
Topics: Depression; Fluphenazine; Humans; Schizophrenia; Suicide | 1969 |
Depressive changes after fluphenazine treatment.
Topics: Depression; Female; Fluphenazine; Humans; Schizophrenia; Suicide | 1969 |
[Complementary neurolepsy].
Topics: Adult; Butyrophenones; Depression; Female; Fluphenazine; Humans; Male; Piperidines; Psychotic Disord | 1966 |